Opicapone Analysis of Health Economic Costs in Clinical Practice in Parkinson's Disease UK Patients with Motor Fluctuations: Findings from the OPTIPARK Study

被引：0
|
作者：
Lees, A.
Reichmann, H.
Magalhaes, D.
Rocha, J.
Soares-da-Silva, P.
机构：
来源：
MOVEMENT DISORDERS | 2021年 / 36卷
关键词：
LEVODOPA; ADJUNCT;
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
505
引用
收藏
页码：S218 / S219
页数：2
相关论文
共 50 条
  • [31] Influence of onset of motor fluctuations in the Opicapone effectiveness in Parkinson's: real-world OPTIPARK study
    Jost, W.
    Reichmann, H.
    Lees, A.
    Marinho, D.
    Magalhaes, D.
    Rocha, J.
    Soares-da-Silva, P.
    EUROPEAN JOURNAL OF NEUROLOGY, 2021, 28 : 382 - 382
  • [32] Opicapone in UK clinical practice: effectiveness, safety and cost analysis in patients with Parkinson's disease
    Schofield, Christine
    Chaudhuri, K. Ray
    Carroll, Camille
    Sharma, Jagdish C.
    Pavese, Nicola
    Evans, Jonathan
    Foltynie, Thomas
    Reichmann, Heinz
    Zurowska, Laura
    Soares-da-Silva, Patricio
    Lees, Andrew
    NEURODEGENERATIVE DISEASE MANAGEMENT, 2022, 12 (02) : 77 - 91
  • [33] Effectiveness and safety of opicapone in Parkinson's disease patients with motor fluctuations: the OPTIPARK open-label study (vol 9, 9, 2020)
    Reichmann, Heinz
    Lees, Andrew
    Rocha, Jose-Francisco
    Magalhaes, Diogo
    Soares-da-Silva, Patricio
    TRANSLATIONAL NEURODEGENERATION, 2020, 9 (01)
  • [34] Effects of Opicapone on Sleep in Patients with Parkinson's Disease and Motor Fluctuations
    Hauser, R.
    Videnovic, A.
    Soares-da-Silva, P.
    Liang, G.
    Olson, K.
    Jen, E.
    Rocha, J. F.
    Klepitskaya, O.
    MOVEMENT DISORDERS, 2021, 36 : S175 - S176
  • [35] Effect of Opicapone and Levodopa on Daily Motor Patterns in Parkinson's disease (PD) Patients with Early Motor Fluctuations: Findings from the Korean ADOPTION Study
    Rocha, J.
    Lee, J.
    Ferreira, J.
    Ma, H.
    Jeon, B.
    MOVEMENT DISORDERS, 2024, 39 : S311 - S311
  • [36] Efficacy, tolerability and adherence of opicapone for Parkinson's disease patients with motor fluctuations
    Bermejo Velasco, P.
    EUROPEAN JOURNAL OF NEUROLOGY, 2019, 26 : 454 - 454
  • [37] Opicapone use in patients with Parkinson's disease with motor fluctuations: experience from a tertiary center
    Ojeda-Lepe, E.
    Munoz-Delgado, L.
    Jesus, S.
    Adarmes-Gomez, A. D.
    Macias-Garcia, D.
    Jaraba, M. V. Jimenez
    Zamora, B. Benitez
    Carrillo, F.
    Mir, P.
    MOVEMENT DISORDERS, 2022, 37 : S461 - S461
  • [38] Randomized, Controlled Study of Opicapone in Japanese Parkinson's Patients With Motor Fluctuations
    Takeda, Atsushi
    Takahashi, Ryosuke
    Tsuboi, Yoshio
    Nomoto, Masahiro
    Maeda, Tetsuya
    Nishimura, Akihisa
    Yoshida, Kazuo
    Hattori, Nobutaka
    MOVEMENT DISORDERS, 2021, 36 (02) : 415 - 423
  • [39] Influence of disease duration in the Opicapone effectiveness in Parkinson's patients: real-world OPTIPARK study
    Warnecke, T.
    Reichmann, H.
    Lees, A.
    Marinho, D.
    Magalhaes, D.
    Rocha, J. F.
    Soares-da-Silva, P.
    EUROPEAN JOURNAL OF NEUROLOGY, 2021, 28 : 904 - 904
  • [40] ONSET OF DRUG-RELATED ADVERSE EVENTS IN PARKINSON'S DISEASE PATIENTS TREATED WITH OPICAPONE IN CLINICAL PRACTICE: OPTIPARK POST-HOC ANALYSIS
    Lees, A.
    Reichmann, H.
    Rocha, J. F.
    Magalhaes, D.
    Soares-da-Silva, P.
    PARKINSONISM & RELATED DISORDERS, 2020, 79 : E61 - E62
12345